Work by Peng's group showed that tumor-derived fibroblasts secreted MCP-1 (known as CCL2), the ligand for CCR2 or CCR4, and RANTES (known as CCL5), the ligand for CCR1, CCR3, or CCR5. Here, CCL2 is linked to neoplasm.